Improving Targeted Molecule Generation through Language Model Fine-Tuning Via Reinforcement Learning
- URL: http://arxiv.org/abs/2405.06836v1
- Date: Fri, 10 May 2024 22:19:12 GMT
- Title: Improving Targeted Molecule Generation through Language Model Fine-Tuning Via Reinforcement Learning
- Authors: Salma J. Ahmed, Mustafa A. Elattar,
- Abstract summary: We introduce an innovative de-novo drug design strategy, which harnesses the capabilities of language models to devise targeted drugs for specific proteins.
Our method integrates a composite reward function, combining considerations of drug-target interaction and molecular validity.
- Score: 0.0
- License: http://creativecommons.org/licenses/by-nc-nd/4.0/
- Abstract: Developing new drugs is laborious and costly, demanding extensive time investment. In this study, we introduce an innovative de-novo drug design strategy, which harnesses the capabilities of language models to devise targeted drugs for specific proteins. Employing a Reinforcement Learning (RL) framework utilizing Proximal Policy Optimization (PPO), we refine the model to acquire a policy for generating drugs tailored to protein targets. Our method integrates a composite reward function, combining considerations of drug-target interaction and molecular validity. Following RL fine-tuning, our approach demonstrates promising outcomes, yielding notable improvements in molecular validity, interaction efficacy, and critical chemical properties, achieving 65.37 for Quantitative Estimation of Drug-likeness (QED), 321.55 for Molecular Weight (MW), and 4.47 for Octanol-Water Partition Coefficient (logP), respectively. Furthermore, out of the generated drugs, only 0.041\% do not exhibit novelty.
Related papers
- Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
We propose a novel and general alignment framework to align pretrained target diffusion models with preferred functional properties, named AliDiff.
AliDiff shifts the target-conditioned chemical distribution towards regions with higher binding affinity and structural rationality, specified by user-defined reward functions.
We show that AliDiff can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score, while maintaining strong molecular properties.
arXiv Detail & Related papers (2024-07-01T06:10:29Z) - Latent Chemical Space Searching for Plug-in Multi-objective Molecule Generation [9.442146563809953]
We develop a versatile 'plug-in' molecular generation model that incorporates objectives related to target affinity, drug-likeness, and synthesizability.
We identify PSO-ENP as the optimal variant for multi-objective molecular generation and optimization.
arXiv Detail & Related papers (2024-04-10T02:37:24Z) - Mol-AIR: Molecular Reinforcement Learning with Adaptive Intrinsic Rewards for Goal-directed Molecular Generation [0.0]
Mol-AIR is a reinforcement learning-based framework using adaptive intrinsic rewards for goal-directed molecular generation.
In benchmark tests, Mol-AIR demonstrates superior performance over existing approaches in generating molecules with desired properties.
arXiv Detail & Related papers (2024-03-29T10:44:51Z) - Tailoring Molecules for Protein Pockets: a Transformer-based Generative
Solution for Structured-based Drug Design [133.1268990638971]
De novo drug design based on the structure of a target protein can provide novel drug candidates.
We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
arXiv Detail & Related papers (2022-08-30T09:32:39Z) - Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based
Reinforcement Learning Model [4.815696666006742]
Structure-based de novo method can overcome the data scarcity of active by incorporating drug-target interaction into deep generative architectures.
Here, we demonstrate a widely used and fast protein sequence-based reinforcement learning model for drug discovery.
As a proof of concept, the RL model was utilized to design molecules for four targets.
arXiv Detail & Related papers (2022-08-14T10:41:52Z) - De novo design of protein target specific scaffold-based Inhibitors via
Reinforcement Learning [8.210294479991118]
Current approaches to develop molecules for a target protein are intuition-driven, hampered by slow iterative design-test cycles.
We propose a novel framework, called 3D-MolGNN$_RL$, coupling reinforcement learning to a deep generative model based on 3D-Scaffold.
Our approach can serve as an interpretable artificial intelligence (AI) tool for lead optimization with optimized activity, potency, and biophysical properties.
arXiv Detail & Related papers (2022-05-21T00:47:35Z) - Molecular Attributes Transfer from Non-Parallel Data [57.010952598634944]
We formulate molecular optimization as a style transfer problem and present a novel generative model that could automatically learn internal differences between two groups of non-parallel data.
Experiments on two molecular optimization tasks, toxicity modification and synthesizability improvement, demonstrate that our model significantly outperforms several state-of-the-art methods.
arXiv Detail & Related papers (2021-11-30T06:10:22Z) - Improved Drug-target Interaction Prediction with Intermolecular Graph
Transformer [98.8319016075089]
We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture.
Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively.
IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
arXiv Detail & Related papers (2021-10-14T13:28:02Z) - Benchmarking Deep Graph Generative Models for Optimizing New Drug
Molecules for COVID-19 [11.853524110656991]
Design of new drug compounds with target properties is a key area of research in generative modeling.
We present a small drug molecule design pipeline based on graph-generative models and a comparison study of two state-of-the-art graph generative models for designing COVID-19 targeted drug candidates.
arXiv Detail & Related papers (2021-02-09T17:49:26Z) - Optimizing Molecules using Efficient Queries from Property Evaluations [66.66290256377376]
We propose QMO, a generic query-based molecule optimization framework.
QMO improves the desired properties of an input molecule based on efficient queries.
We show that QMO outperforms existing methods in the benchmark tasks of optimizing small organic molecules.
arXiv Detail & Related papers (2020-11-03T18:51:18Z) - CogMol: Target-Specific and Selective Drug Design for COVID-19 Using
Deep Generative Models [74.58583689523999]
We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins.
CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme.
CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
arXiv Detail & Related papers (2020-04-02T18:17:20Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.